Tri-Society Meeting of International Cytokine Society (ICS), International Societ
Tri-Society Meeting of International Cytokine Society (ICS), International Societ
批准号:
7808663
负责人:
Luis J Montaner
金额:
$4.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2010-08-31
关键词:
AddressAreaAutoimmune ProcessBiologyChronicCommunicable DiseasesCytokine GeneDisabled PersonsDiseaseEpigenetic ProcessFunctional disorderFundingGene ExpressionGenesHealthHost DefenseImmuneImmune responseImmunotherapyInflammationInflammatoryInflammatory Response PathwayInterferonsInterleukin-1InternationalJointsLeukocytesMalariaMalignant NeoplasmsMycosesNatural ImmunityOralParticipantPathogenesisPattern recognition receptorPortugalProcessRegulationResearchResearch PersonnelRoleScientistSignal TransductionSocietiesSpecial Exceptions ProcessSpecificityToll-like receptorsUnderrepresented MinorityVaccinesViral PathogenesisVirus DiseasesWomanWorkabstractingadvanced diseasecytokinehospital laboratoriesinnovationmacrophagemast cellmeetingsmembermultidisciplinaryneutrophilnovelpathogenpostersprogramspublic health relevanceresponsesymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the past several years there has been a growing appreciation for the complexity and specificity of the interactions of leukocytes, cytokines, interferons and pathophysiology of cancer and infectious disease. Greater understanding of mechanisms of disease and novel concepts for therapy will emerge from bringing together multi-disciplinary forums where the most advances can be presented and discussed by new and established scientists. This proposal seeks support for junior investigator attendance to the 2009 joint annual meetings of three leading Societies addressing immune host modulation in health and disease (Society for Leukocyte Biology, International Cytokine Society, and the International Society of Interferon and Cytokine Research) entitled, "Cellular and Cytokine Interactions in Health and Disease" to be held in Lisbon. Annual meetings by all three Societies have a long-standing tradition of highlighting the highest quality and most innovative work on the mechanisms underlying cytokine, interferon-related, and leukocyte function in disease pathogenesis (cancer, infectious, autoimmune) and host defense. The 2009 Tri-Society meeting will build in this tradition by bringing together under one roof all members of the three Societies to maximize interaction and benefit for all participants. The Specific Aims of the conference are outlined below.
Specific Aim 1: To provide a forum for 800-1000 participants from academic, governmental and industrial laboratories and hospitals to share recent advances in leukocyte-cytokine/interferon interactions, pathophysiology and host defense. Presentations will include talks by invited speakers as well as talks and poster presentations chosen from submitted abstracts.
Specific Aim 2.: To present a program that captures the most significant advances from the previous year in the following areas: MicroRNA Regulation of Cytokine Gene Expression in Health and Disease, Epigenetic Regulation of Cytokine and Inflammatory Responses, Role of Interferons, Pattern Recognition Receptors, New T-helper Subsets, Neutrophil Biology, The Macrophages in Health and Disease, T-regs and Vaccines, Viral Infections & Inflammation, Control of Innate Immunity, Cytokines and Cancer, Recent Advances in Cytokine and IFN signaling. Inflammasome activation and the role of IL-1 and Mast Cells, IFN-stimulated genes, Innate Recognition of Pathogens, Pathogen interactions with Toll-like receptors: TB and Malaria, Pathogen Manipulation of Cytokine Responses Cytokines and viral pathogenesis, Sensing of fungal infection and host response, Chronic Inflammatory Disease and Immunotherapy.
Specific Aim 3: To provide an opportunity for young investigators and trainees to interact closely with well-established researchers in their fields and to present their research in poster or oral presentations.
Specific Aim 4: To provide an opportunity for women, under-represented minorities and persons with disabilities to participate in a meeting that showcases their work and facilitates interactions with other scientists in their fields.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Purchase of MVE Fusion Self-Sustaining Cryogenic Freezers
-
批准号:10533525
-
项目类别:
-
资助金额:$11.05万
-
财政年份:2022
-
负责人:Luis J Montaner
-
依托单位:
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
-
批准号:10469617
-
项目类别:
-
资助金额:$583.97万
-
财政年份:2021
-
负责人:Luis J Montaner
-
依托单位:
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
-
批准号:10609926
-
项目类别:
-
资助金额:$578.07万
-
财政年份:2021
-
负责人:Luis J Montaner
-
依托单位:
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
-
批准号:10313067
-
项目类别:
-
资助金额:$610.0万
-
财政年份:2021
-
负责人:Luis J Montaner
-
依托单位:
First-in-human study of two anti-SARS CoV-2 antibodies in health volunteers
-
批准号:10291661
-
项目类别:
-
资助金额:$157.16万
-
财政年份:2021
-
负责人:Luis J Montaner
-
依托单位:
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
-
批准号:10621847
-
项目类别:
-
资助金额:$76.62万
-
财政年份:2019
-
负责人:Luis J Montaner
-
依托单位:
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
-
批准号:10381326
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2019
-
负责人:Luis J Montaner
-
依托单位:
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
-
批准号:10406244
-
项目类别:
-
资助金额:$92.56万
-
财政年份:2019
-
负责人:Luis J Montaner
-
依托单位:
Towards Eradication: Reducing Proviral HIV DNA with Interferon-a Immunotherapy
-
批准号:8671884
-
项目类别:
-
资助金额:$170.84万
-
财政年份:2014
-
负责人:Luis J Montaner
-
依托单位:
Purchase a Beckman Coulter MoFlo Astrios Flow Cytometer
-
批准号:8639790
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2014
-
负责人:Luis J Montaner
-
依托单位:
Towards Eradication: Reducing Proviral HIV DNA with Interferon-α Immunotherapy
-
批准号:8988529
-
项目类别:
-
资助金额:$183.73万
-
财政年份:2014
-
负责人:Luis J Montaner
-
依托单位:
Flowcore Upgrade: Amnis ImageStream Flow Cytometer
-
批准号:7794705
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2010
-
负责人:Luis J Montaner
-
依托单位:
Pediatric Immune Correlates of Early Anti-HIV Therapy
-
批准号:8049900
-
项目类别:
-
资助金额:$51.5万
-
财政年份:2010
-
负责人:Luis J Montaner
-
依托单位:
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
-
批准号:8601696
-
项目类别:
-
资助金额:$70.1万
-
财政年份:2010
-
负责人:Luis J Montaner
-
依托单位:
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
-
批准号:8420534
-
项目类别:
-
资助金额:$67.83万
-
财政年份:2010
-
负责人:Luis J Montaner
-
依托单位:
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
-
批准号:8213606
-
项目类别:
-
资助金额:$67.89万
-
财政年份:2010
-
负责人:Luis J Montaner
-
依托单位:
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
-
批准号:8044828
-
项目类别:
-
资助金额:$66.55万
-
财政年份:2010
-
负责人:Luis J Montaner
-
依托单位:
Flow Cytometry
-
批准号:7945002
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2009
-
负责人:Luis J Montaner
-
依托单位:
Innate Effector Function and HIV-1 Control
-
批准号:7620589
-
项目类别:
-
资助金额:$26.24万
-
财政年份:2009
-
负责人:Luis J Montaner
-
依托单位:
Innate Effector Function and HIV-1 Control
-
批准号:7847484
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2009
-
负责人:Luis J Montaner
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: